Signal included drugs from Eli Lilly, AstraZeneca, Sanofi Does not mean medicine caused any reported adverse event Novo shares down 1%, after earlier more than 2% drop COPENHAGEN, June 22 (Reuters) - ...
At its July 2025 meeting, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended refusing marketing authorization for Jelrix (autologous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback